Japan Tissue Engineering Co., Ltd. Logo

Japan Tissue Engineering Co., Ltd.

Pioneers regenerative medicine with tissue products, CDMO services, and research models.

7774 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
蒲郡市三谷北通6丁目209番地の1
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Japan Tissue Engineering Co., Ltd. (J-TEC) is a pioneering biotechnology company focused on the commercialization of regenerative medicine. The company operates through three primary segments: the Regenerative Medicine Business, which develops, manufactures, and sells tissue-engineered medical products such as autologous cultured cartilage; the Custom Development & Manufacturing (CDMO) Business, offering contract services for cell and gene therapy developers; and the LabCyte Business, providing cultured human tissue models for research and safety testing. A member of the Teijin Group, J-TEC was the first company to commercialize regenerative medicine in Japan and aims to establish it as a standard of care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-19 10:05
Post-Annual General Meeting Information
臨時報告書
Japanese 27.0 KB
2025-06-19 07:20
Governance Information
内部統制報告書-第27期(2024/04/01-2025/03/31)
Japanese 21.7 KB
2025-06-19 07:18
Registration Form
確認書
Japanese 8.3 KB
2025-06-19 07:16
Annual Report
有価証券報告書-第27期(2024/04/01-2025/03/31)
Japanese 920.6 KB
2024-11-13 06:09
Regulatory News Service
確認書
Japanese 8.2 KB
2024-11-13 06:07
Interim Report
半期報告書-第27期(2024/04/01-2025/03/31)
Japanese 188.4 KB
2024-06-19 07:50
Post-Annual General Meeting Information
臨時報告書
Japanese 22.1 KB
2024-06-19 07:48
Governance Information
内部統制報告書-第26期(2023/04/01-2024/03/31)
Japanese 21.5 KB
2024-06-19 07:46
Registration Form
確認書
Japanese 8.3 KB
2024-06-19 07:45
Annual Report
有価証券報告書-第26期(2023/04/01-2024/03/31)
Japanese 907.6 KB
2024-02-13 06:39
Regulatory News Service
確認書
Japanese 8.3 KB
2024-02-13 06:38
Quarterly Report
四半期報告書-第26期第3四半期(2023/10/01-2023/12/31)
Japanese 169.5 KB
2023-11-14 07:22
Report Publication Announcement
確認書
Japanese 8.3 KB
2023-11-14 07:18
Quarterly Report
四半期報告書-第26期第2四半期(2023/07/01-2023/09/30)
Japanese 195.9 KB
2023-08-10 08:23
Report Publication Announcement
確認書
Japanese 8.3 KB

Automate Your Workflow. Get a real-time feed of all Japan Tissue Engineering Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Japan Tissue Engineering Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea 397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780

Talk to a Data Expert

Have a question? We'll get back to you promptly.